Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.

ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

MET-097 is a glucagon-like peptide 1 receptor (GLP-1R) agonist developed at Metsera for treating overweight and obesity and is currently in phase II clinical trials.

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...

For years, researchers have seen a connection between exercise and the progression of cognitive disorders such as Alzheimer's ...

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical ...

The Creston Police Department says Jessica Jo England was arrested at around 6:40 p.m. for possession of a controlled ...

Gemcitabine, a drug with established efficacy against a number of solid tumors, has therapeutic limitations due to its rapid metabolic inactivation. The aim of this study was the development of an ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Pharmacology is a branch of biomedical science, encompassing clinical pharmacology, that is concerned with the effects of drugs/pharmaceuticals and other xenobiotics on living systems, ...

Pharmacokinetic properties Pitavastatin undergoes biliary excretion and enterohepatic circulation. CYP2C9 and CYP2C8 interact with pitavastatin, although resulting in negligible metabolism.